Short-Chain Fatty Acids Induce Pro-Inflammatory Cytokine Production Alone and in Combination with Toll-Like Receptor Ligands

American Journal of Reproductive Immunology

Volumn 67, Issue 5, 2012, Pages 391-400

  Mirmonsef, Paria ^a   Zariffard, Mohammad R ^a   Gilbert, Douglas ^a   Makinde, Hadijat ^a   Landay, Alan L ^a   Spear, Greg T ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bacterial vaginosis; Inflammation; Short chain fatty acids

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; SHORT CHAIN FATTY ACID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 7; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL SYSTEM; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

CELLS, CULTURED; CYTOKINES; FATTY ACIDS, VOLATILE; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; LIGANDS; MALE; NEUTROPHILS; REACTIVE OXYGEN SPECIES; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 7; VAGINOSIS, BACTERIAL;

EID: 84859701470     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2011.01089.x     Document Type: Article

References (42)

1. Schenten D, Medzhitov R: The control of adaptive immune responses by the innate immune system. Adv Immunol 2011; 109:87-124.
2. Kawai T, Akira S: Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity. Immunity 2011; 34:637-650.
3. Maloy KJ, Powrie F: Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011; 474:298-306.
4. Sandler NG, Koh C, Roque A, Eccleston JL, Siegel RB, Demino M, Kleiner DE, Deeks SG, Liang TJ, Heller T, Douek DC: Host Response to Translocated Microbial Products Predicts Outcomes of Patients with HBV or HCV infection. Gastroenterology 2011; 141:1220-1230.
5. Couzin-Frankel J: Inflammation bares a dark side. Science 2010; 330:1621.
6. Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, Mandaliya K, Ndinya-Achola JO, Bwayo J, Kreiss J: Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999; 180:1863-1868.
7. Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim D, Wabwire-Mangen F, Serwadda D, Li C, Kiwanuka N, Hillier SL, Rabe L, Gaydos CA, Quinn TC, Konde-Lule J: HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis [see comments] [published erratum appears in Lancet 1997 Oct 4; 350(9083):1036]. Lancet 1997; 350:546-550.
8. Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LA, Yang LP, Liomba GN, Broadhead RL, Chiphangwi JD, Miotti PG: Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. Aids 1998; 12:1699-1706.
9. Sha BE, Zariffard MR, Wang QJ, Chen HY, Bremer J, Cohen MH, Spear GT: Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis 2005; 191:25-32.
10. Lavelle EC, Murphy C, O'Neill LA, Creagh EM: The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis. Mucosal Immunol 2010; 3:17-28.
11. Roy CC, Kien CL, Bouthillier L, Levy E: Short-chain fatty acids: ready for prime time? Nutr Clin Pract 2006; 21:351-366.
12. Al-Mushrif S, Eley A, Jones BM: Inhibition of chemotaxis by organic acids from anaerobes may prevent a purulent response in bacterial vaginosis. J Med Microbiol 2000; 49:1023-1030.
13. Chaudry AN, Travers PJ, Yuenger J, Colletta L, Evans P, Zenilman JM, Tummon A: Analysis of vaginal acetic acid in patients undergoing treatment for bacterial vaginosis. J Clin Microbiol 2004; 42:5170-5175.
14. Niederman R, Zhang J, Kashket S: Short-chain carboxylic-acid-stimulated, PMN-mediated gingival inflammation. Crit Rev Oral Biol Med 1997; 8:269-290.
15. Sellin JH: SCFAs: the enigma of weak electrolyte transport in the colon. News Physiol Sci 1999; 14:58-64.
16. Preti GH: The Human Vagina. Amsterdam/New York, Elsevier North- Holland Biomedical Press, 1978.
17. Mirmonsef P, Gilbert D, Zariffard MR, Hamaker BR, Kaur A, Landay AL, Spear GT: The effects of commensal bacteria on innate immune responses in the female genital tract. Am J Reprod Immunol 2011; 65:190-195.
18. Tedelind S, Westberg F, Kjerrulf M, Vidal A: Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol 2007; 13:2826-2832.
19. Segain JP, Raingeard de la Bletiere D, Bourreille A, Leray V, Gervois N, Rosales C, Ferrier L, Bonnet C, Blottiere HM, Galmiche JP: Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 2000; 47:397-403.
20. Luhrs H, Gerke T, Muller JG, Melcher R, Schauber J, Boxberge F, Scheppach W, Menzel T: Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol 2002; 37:458-466.
21. Luhrs H, Kudlich T, Neumann M, Schauber J, Melcher R, Gostner A, Scheppach W, Menzel TP: Butyrate-enhanced TNFalpha-induced apoptosis is associated with inhibition of NF-kappaB. Anticancer Res 2002; 22:1561-1568.
22. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teixeira MM, Mackay CR: Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009; 461:1282-1286.
23. Cox MA, Jackson J, Stanton M, Rojas-Triana A, Bober L, Laverty M, Yang X, Zhu F, Liu J, Wang S, Monsma F, Vassileva G, Maguire M, Gustafson E, Bayne M, Chou CC, Lundell D, Jenh CH: Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines. World J Gastroenterol 2009; 15:5549-5557.
24. Bafica A, Scanga CA, Schito M, Chaussabel D, Sher A: Influence of coinfecting pathogens on HIV expression: evidence for a role of Toll-like receptors. J Immunol 2004; 172:7229-7234.
25. Al-Harthi L, Spear GT, Hashemi FB, Landay A, Sha BE, Roebuck KA: A human immunodeficiency virus (HIV)-inducing factor from the female genital tract activates HIV-1 gene expression through the kappaB enhancer. J Infect Dis 1998; 178:1343-1351.
26. Al-Harthi L, Roebuck KA, Olinger GG, Landay A, Sha BE, Hashemi FB, Spear GT: Bacterial vaginosis-associated microflora isolated from the female genital tract activates HIV-1 expression. J Acquir Immune Defic Syndr 1999; 21:194-202.
27. Hashemi FB, Ghassemi M, Faro S, Aroutcheva A, Spear GT: Induction of HIV-1 Expression by Anaerobes Associated With Bacterial Vaginosis. J Infect Dis 2000; 181:1574-1580.
28. Simoes JA, Hashemi FB, Aroutcheva AA, Heimler I, Spear GT, Shott S, Faro S: Human immunodeficiency virus type 1 stimulatory activity by Gardnerella vaginalis: relationship to biotypes and other pathogenic characteristics. J Infect Dis 2001; 184:22-27.
29. Piccini A, Carta S, Tassi S, Lasiglie D, Fossati G, Rubartelli A: ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci U S A 2008; 105:8067-8072.
30. Vinolo MA, Ferguson GJ, Kulkarni S, Damoulakis G, Anderson K, Bohlooly YM, Stephens L, Hawkins PT, Curi R: SCFAs Induce Mouse Neutrophil Chemotaxis through the GPR43 Receptor. PLoS ONE 2011; 6:e21205.
31. Vinolo MA, Rodrigues HG, Hatanaka E, Hebeda CB, Farsky SH, Curi R: Short-chain fatty acids stimulate the migration of neutrophils to inflammatory sites. Clin Sci (Lond) 2009; 117:331-338.
32. Jin MS, Lee JO: Structures of the toll-like receptor family and its ligand complexes. Immunity 2008; 29:182-191.
33. Rada B, Leto TL: Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib Microbiol 2008; 15:164-187.
34. West AP, Shadel GS, Ghosh S: Mitochondria in innate immune responses. Nat Rev Immunol 2011; 11:389-402.
35. Meijer K, de Vos P, Priebe MG: Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health? Curr Opin Clin Nutr Metab Care 2010; 13:715-721.
36. Bailon E, Cueto-Sola M, Utrilla P, Rodriguez-Cabezas ME, Garrido-Mesa N, Zarzuelo A, Xaus J, Galvez J, Comalada M: Butyrate in vitro immune-modulatory effects might be mediated through a proliferation-related induction of apoptosis. Immunobiology 2010; 215:863-873.
37. Cavaglieri CR, Nishiyama A, Fernandes LC, Curi R, Miles EA, Calder PC: Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci 2003; 73:1683-1690.
38. Lardner A: The effects of extracellular pH on immune function. J Leukoc Biol 2001; 69:522-530.
39. Kantor B, Ma H, Webster-Cyriaque J, Monahan PE, Kafri T: Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection. Proc Natl Acad Sci U S A 2009; 106:18786-18791.
40. Quivy V, Adam E, Collette Y, Demonte D, Chariot A, Vanhulle C, Berkhout B, Castellano R, de Launoit Y, Burny A, Piette J, Bours V, Van Lint C: Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies. J Virol 2002; 76:11091-11103.
41. Sanderson IR: Short chain fatty acid regulation of signaling genes expressed by the intestinal epithelium. J Nutr 2004; 134:2450S-2454S.
42. Laughlin MA, Zeichner S, Kolson D, Alwine JC, Seshamma T, Pomerantz RJ, Gonzalez-Scarano F: Sodium butyrate treatment of cells latently infected with HIV-1 results in the expression of unspliced viral RNA. Virology 1993; 196:496-505.